Lung Pathology

Overview

Lung Pathology CME from the Experts

Through engaging lectures, case studies, and virtual microscopy sessions, Masters of Pathology Series – Lung Pathology continuing medical education helps build and translate knowledge into realistic diagnostic scenarios. Course Director Lynette M. Sholl, MD, and her colleagues deliver in-depth coverage of topics like granulomatous diseases, vasculitis, multiple lung tumors, lung transplant pathology, pulmonary vascular pathology, benign mimics of lung cancer, and more. This online CME course will help you to better:

• Recognize common, uncommon mediastinal tumors including thymic neoplasms
• Interpret the clinical implications of specific carcinoma diagnoses
• Identify effective diagnostic and predictive biomarkers for NSCLC diagnosis
• Differentiate between reactive and neoplastic proliferations of the lung and pleura
• Understand the relevance of IHC, FISH, molecular tests for diagnosing malignant mesothelioma
• Define appropriate biomarkers to select lung cancer patients for immunotherapy

Topics / Speakers

Pleura

Mesothelioma
Marina Vivero, MD

Lymphohistiocytic Neoplasms of the Lung and Pleura and their Differential - A Pulmonary Pathologist's Perspective
Lynette M. Sholl, MD

Mediastinum

Thymic Pathology: Hyperplasia, Thymoma, and Neuroendocrine Tumors
Lynette M. Sholl, MD

Thymic Carcinoma and other Anterior Mediastinal Malignancies
Lynette M. Sholl, MD

Neuroendocrine Tumors

Typical and Atypical Carcinoid and Precursor Lesions
Marina Vivero, MD

High Grade Neuroendocrine Carcinomas of the Lung
Lynette M. Sholl, MD

Non-Small Cell Lung Carcinomas

Clinical and Pathologic Features of Pulmonary Squamous Cell Carcinoma
Lynette M. Sholl, MD

Clinical and Pathologic Features of Adenocarcinoma of the Lung
Lynette M. Sholl, MD

Lepidic-Predominant Tumors: Rules for Classification and Implications for Staging
Lynette M. Sholl, MD

Poorly Differentiated and Undifferentiated Tumors of the Lung
Lynette M. Sholl, MD

Benign Mimics of Lung Cancer
Lynette M. Sholl, MD

Immunohistochemistry for Lung Cancer

Immunohistochemistry for Lung Carcinomas: Diagnosis
Lynette M. Sholl, MD

Immunohistochemistry for Lung Cancer: Prediction
Lynette M. Sholl, MD

Biomarkers in Lung Cancer

Genomic Biomarkers for Non Small Cell Lung Carcinoma
Lynette M. Sholl, MD

Overview of Immunotherapy Biomarkers for NSCLC
Lynette M. Sholl, MD

Interstitial Lung Diseases

Interstitial Lung Disease Pathology
Robert F. Padera, Jr., MD, PhD

Granulomatous Diseases
Lynette M. Sholl, MD

Microscopy Session: Infectious Diseases
Robert F. Padera, Jr., MD, PhD

Connective Tissue Disease - Interstitial Lung Disease
Marina Vivero, MD

Lung Transplant Pathology
Robert F. Padera, Jr., MD, PhD

Smoking - Related Lung Diseases
Lynette M. Sholl, MD

Pulmonary Vascular Pathology
Robert F. Padera, Jr., MD, PhD

Vasculitis
Lynette M. Sholl, MD

Survival Sessions

Managing Small Biopsies for Lung Cancer - Specimen Handling for Optimal Diagnostic and Predictive Testing
Lynette M. Sholl, MD

Microscopy Session: Interpretation of PD-L1 Immunohistochemistry
Lynette M. Sholl, MD

Atypical Epithelial Proliferation in the Lung: Is It Reactive or Neoplastic?
Lynette M. Sholl, MD

Multiple Lung Tumors: Same or Different?
Lynette M. Sholl, MD

Potpourri of Pulmonary Problems: Special T, N, M Challenges in Lung Cancer Pathology
Lynette M. Sholl, MD

Microscopy Session: Cytology of Lung Cancers
Marina Vivero, MD

Reactive Pleuritis vs. Mesothelioma - Making the Distinction
Lynette M. Sholl, MD

Faculty

Course Director

Faculty

Accreditation

Accreditation Statement

Oakstone Publishing is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation

Oakstone Publishing designates this enduring material for a maximum of 15.75 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Reviewed for Re-Release: June 1, 2022
Date Credits Expire: June 1, 2025
Date of Original Release: June 1, 2019

CME credit is awarded upon successful completion of a course evaluation and post-test.

This activity has been registered as a Lifelong Learning (Part II) and Self-Assessment Module (SAM) to offer credits in the American Board of Pathology's (ABPath) Continuing Certification program.

Learning Objectives

At the conclusion of this activity, the participant will be able to:

• Identify the pathologic and immunohistochemical features of common lung carcinomas and understand the clinical implications of specific carcinoma diagnoses
• Identify the crucial diagnostic and predictive biomarkers for non-small cell lung carcinomas and understand how to apply them in clinical practice
• Define appropriate biomarkers for selection of lung cancer patients for immunotherapy
• Distinguish between reactive and neoplastic proliferations of the lung and pleura
• Classify correctly primary and metastatic mimics of non-small cell lung carcinomas
• Recognize common and uncommon mediastinal tumors including thymic neoplasms
• Recognize clinically significant interstitial changes in the lung in patients with and without prospectively recognized clinical and radiographic correlates

Intended Audience

This educational activity was designed for practicing pathologists, oncologists, pulmonologists, and pathology assistants.

Quick Facts

Masters of Pathology Series Provider: Oakstone CME

Course Director:
Lynette M. Sholl, MD
Associate Pathologist

Brigham and Women’s Hospital

Associate Professor

Harvard Medical School

Boston, MA

Credits: Earn a maximum of 15.75 AMA PRA Category 1 Credits ™